The Allianz-backed company, which is developing treatments for inner ear disorders, has set the range for its initial public offering between $10 and $12.

Heart monitor developer Cardiac Insight has raised $7m in a series B round featuring Welch Allyn, a medical device maker with which it has signed a distribution deal.

Healthcare software provider Essence Group Holdings raised its overall funding to about $185m after raising $71m in a Sandbox Industries-backed round.

InoCardia has secured the investment from Mercia Fund Management.

Amcure, a spinout of the Karlsruhe Institute of Technology, has raised $6.7m from LBBW's venture capital subsidiary.

Medical image provider Dicom Grid has raised $6m in new funding from backers including Mayo Clinic.

Clinical stage pharmaceutical company Virobay has raised $10m in a second tranche of series B funding to bring the total value of the round to $18m.

Edico Genome has raised $10m from Qualcomm Ventures and Axon to accelerate the analysis of gene sequencing data.

Portland State startup has secured the investment in a second round of angel funding.

Aberdeen spin-out TauRx has reached its enrolment target for a phase III clinical trial.